1 |
Bucciantini, M., G. Calloni, F. Chiti, L. Formigli, D. Nosi, C. M. Dobson, and M. Stefani. 2004. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279: 31374-31382.
DOI
ScienceOn
|
2 |
Buxbaum, J. N. 2003. Diseases of protein conformation: What do in vitro experiments tell us about in vivo diseases? Trends Biochem. Sci. 28: 585-592.
DOI
ScienceOn
|
3 |
Cantin, G. T., T. R. Shock, S. K. Park, H. D. Madhani, and J. R. Yates 3rd. 2007. Optimizing-based phosphopeptide enrichment for automated multidimensional liquid chromatography coupled to tandem mass spectrometry. Anal. Chem. 79: 4666- 4673.
DOI
ScienceOn
|
4 |
Choe, L., M. D'Ascenzo, N. R. Relkin, D. Pappin, P. Ross, B. Williamson, et al. 2007. 8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics 7: 3651-3660.
DOI
ScienceOn
|
5 |
Cohen, F. E. and J. W. Kelly. 2003. Therapeutic approaches to protein-misfolding diseases. Nature 426: 905-909.
DOI
ScienceOn
|
6 |
Chong, P. K., C. S. Gan, T. K. Pham, and P. C. Wright. 2006. Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections. J. Proteome Res. 5: 1232-1240.
DOI
ScienceOn
|
7 |
Chong, P. K., H. Lee, J. W. Kong, M. C. Loh, C. H. Wong, and Y. P. Lim. 2008. Phosphoproteomics, oncogenic signaling and cancer research. Proteomics 8: 4370-4382.
DOI
ScienceOn
|
8 |
Choudhary, C. and M. Mann. 2010. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11: 427-439.
DOI
ScienceOn
|
9 |
Cohen, P. 2000. The regulation of protein function by multisite phosphorylation - a 25 year update. Trends Biochem. Sci. 25: 596-601.
DOI
ScienceOn
|
10 |
Cohen, P. 2002. The origins of protein phosphorylation. Nat. Cell Biol. 4: E127-E130.
DOI
ScienceOn
|
11 |
Dawson, T. M. and V. L. Dawson. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
DOI
ScienceOn
|
12 |
De Meyts, P. and J. Whittaker. 2002. Structural biology of insulin and IGF1 receptors: Implications for drug design. Nat. Rev. Drug Discov. 1: 769-783.
DOI
ScienceOn
|
13 |
Di Domenico, F., R. Sultana, E. Barone, M. Perluigi, C. Cini, C. Mancuso, et al. 2011. Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects. J. Proteomics 74: 1091-1103.
DOI
ScienceOn
|
14 |
Gannon, J., L. Staunton, K. O'Connell, P. Doran, and K. Ohlendieck. 2008. Phosphoproteomic analysis of aged skeletal muscle. Int. J. Mol. Med. 22: 33-42.
|
15 |
DiFiglia, M., E. Sapp, K. O. Chase, S. W. Davies, G. P. Bates, J. P. Vonsattel, and N. Aronin. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990-1993.
DOI
|
16 |
Dobson, C. M. 2003. Protein folding and misfolding. Nature 426: 884-890.
DOI
ScienceOn
|
17 |
Figeys, D., S. P. Gygi, G. McKinnon, and R. Aebersold. 1998. An integrated microfluidics-tandem mass spectrometry system for automated protein analysis. Anal. Chem. 70: 3728-3734.
DOI
ScienceOn
|
18 |
Gerber, S. A., J. Rush, O. Stemman, M. W. Kirschner, and S. P. Gygi. 2003. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100: 6940-6945.
DOI
ScienceOn
|
19 |
Goedert, M. 2004. Tau protein and neurodegeneration. Semin. Cell Dev. Biol. 15: 45-49.
DOI
ScienceOn
|
20 |
Goedert, M. 1993. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16: 460-465.
DOI
ScienceOn
|
21 |
Gruhler, A., J. V. Olsen, S. Mohammed, P. Mortensen, N. J. Faergeman, M. Mann, and O. N. Jensen. 2005. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell Proteomics 4: 310-327.
DOI
ScienceOn
|
22 |
Guo, A., J. Villen, J. Kornhauser, K. A. Lee, M. P. Stokes, K. Rikova, et al. 2008. Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. USA 105: 692-697.
DOI
ScienceOn
|
23 |
Jensen, O. N. 2004. Modification-specific proteomics: Characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 8: 33-41.
DOI
ScienceOn
|
24 |
Gygi, S. P., B. Rist, S. A. Gerber, F. Turecek, M. H. Gelb, and R. Aebersold. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17: 994-999.
DOI
ScienceOn
|
25 |
Hunter, T. 2000. Signaling - 2000 and beyond. Cell 100: 113-127.
DOI
ScienceOn
|
26 |
Ingram, E. M. and M. G. Spillantini. 2002. Tau gene mutations: Dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8: 555-562.
DOI
ScienceOn
|
27 |
Jensen, O. N. 2006. Interpreting the protein language using proteomics. Nat. Rev. Mol. Cell Biol. 7: 391-403.
DOI
ScienceOn
|
28 |
Jensen, S. S. and M. R. Larsen. 2007. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun. Mass Spectrom. 21: 3635-3645.
DOI
ScienceOn
|
29 |
Kirkpatrick, D. S., S. A. Gerber, and S. P. Gygi. 2005. The absolute quantification strategy: A general procedure for the quantification of proteins and post-translational modifications. Methods 35: 265-273.
DOI
ScienceOn
|
30 |
Kosako, H. and K. Nagano. 2011. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Expert Rev. Proteomics 8: 81-94.
DOI
ScienceOn
|
31 |
Kweon, H. K. and K. Hakansson. 2006. Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis. Anal. Chem. 78: 1743-1749.
DOI
ScienceOn
|
32 |
Mann, M. and O. N. Jensen. 2003. Proteomic analysis of posttranslational modifications. Nat. Biotechnol. 21: 255-261.
DOI
ScienceOn
|
33 |
Lam, M. P., S. O. Siu, E. Lau, X. Mao, H. Z. Sun, P. C. Chiu, et al. 2010. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization. Anal. Bioanal. Chem. 398: 791-804.
DOI
|
34 |
Larsen, M. R., T. E. Thingholm, O. N. Jensen, P. Roepstorff, and T. J. Jorgensen. 2005. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell Proteomics 4: 873-886.
DOI
ScienceOn
|
35 |
Lopez, E., I. Lopez, A. Ferreira, and J. Sequi. 2011. Clinical and technical phosphoproteomic research. Proteome Sci. 9: 27.
DOI
|
36 |
Mann, M., S. E. Ong, M. Gronborg, H. Steen, O. N. Jensen, and A. Pandey. 2002. Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol. 20: 261-268.
DOI
ScienceOn
|
37 |
Manning, G., D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002. The protein kinase complement of the human genome. Science 298: 1912-1934.
DOI
ScienceOn
|
38 |
Mattson, M. P. 2004. Pathways towards and away from Alzheimer's disease. Nature 430: 631-639.
DOI
ScienceOn
|
39 |
Mazanek, M., G. Mituloviae, F. Herzog, C. Stingl, J. R. Hutchins, J. M. Peters, and K. Mechtler. 2007. Titanium dioxide as a chemoaffinity solid phase in offline phosphopeptide chromatography prior to HPLC-MS/MS analysis. Nat. Protoc. 2: 1059-1069.
DOI
ScienceOn
|
40 |
McNulty, D. E. and R. S. Annan. 2008. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol. Cell Proteomics 7: 971-980.
DOI
ScienceOn
|
41 |
Motoyama, A., T. Xu, C. I. Ruse, J. A. Wohlschlegel, and J. R. Yates 3rd. 2007. Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides. Anal. Chem. 79: 3623-3634.
DOI
ScienceOn
|
42 |
Moorhead, G. B., L. Trinkle-Mulcahy, and A. Ulke-Lemee. 2007. Emerging roles of nuclear protein phosphatases. Nat. Rev. Mol. Cell Biol. 8: 234-244.
DOI
ScienceOn
|
43 |
Morales, M. A., R. Watanabe, C. Laurent, P. Lenormand, J. C. Rousselle, A. Namane, and G. F. Spath. 2008. Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages. Proteomics 8: 350-363.
DOI
ScienceOn
|
44 |
Moser, K. and F. M. White. 2006. Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J. Proteome Res. 5: 98-104.
DOI
ScienceOn
|
45 |
Mumby, M. and D. Brekken. 2005. Phosphoproteomics: New insights into cellular signaling. Genome Biol. 6: 230.
DOI
|
46 |
Neville, D. C., C. R. Rozanas, E. M. Price, D. B. Gruis, A. S. Verkman, and R. R. Townsend. 1997. Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 6: 2436-2445.
|
47 |
Oka, T., K. Tagawa, H. Ito, and H. Okazawa. 2011. Dynamic changes of the phosphoproteome in postmortem mouse brains. PLoS One 6: e21405.
DOI
|
48 |
Olsen, J. V. and M. Mann. 2004. Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc. Natl. Acad. Sci. USA 101: 13417-13422.
DOI
ScienceOn
|
49 |
Ong, S. E., B. Blagoev, I. Kratchmarova, D. B. Kristensen, H. Steen, A. Pandey, and M. Mann. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1: 376-386.
DOI
ScienceOn
|
50 |
Ashman, K. and E. L. Villar. 2009. Phosphoproteomics and cancer research. Clin. Transl. Oncol. 11: 356-362.
DOI
|
51 |
Alpert, A. J. 1990. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 499: 177-196.
DOI
ScienceOn
|
52 |
Alpert, A. J. and P. C. Andrews. 1988. Cation-exchange chromatography of peptides on poly(2-sulfoethyl aspartamide)- silica. J. Chromatogr. 443: 85-96.
DOI
ScienceOn
|
53 |
Andersson, L. and J. Porath. 1986. Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal. Biochem. 154: 250-254.
DOI
ScienceOn
|
54 |
Barr, J. R., V. L. Maggio, D. G. Patterson Jr., G. R. Cooper, L. O. Henderson, W. E. Turner, et al. 1996. Isotope dilution-mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-I. Clin. Chem. 42: 1676-1682.
|
55 |
Peng, J., J. E. Elias, C. C. Thoreen, L. J. Licklider, and S. P. Gygi. 2003. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome. J. Proteome Res. 2: 43-50.
DOI
ScienceOn
|
56 |
Piggee, C. 2009. Phosphoproteomics: Miles to go before it's routine. Anal. Chem. 81: 2418-2420.
DOI
ScienceOn
|
57 |
Ong, S. E. and M. Mann. 2006. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 1: 2650-2660.
|
58 |
Ozlu, N., B. Akten, W. Timm, N. Haseley, H. Steen, and J. A. Steen. 2010. Phosphoproteomics. Wiley Interdiscip Rev. Syst. Biol. Med. 2: 255-276.
DOI
ScienceOn
|
59 |
Pinkse, M. W., P. M. Uitto, M. J. Hilhorst, B. Ooms, and A. J. Heck. 2004. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLCESI- MS/MS and titanium oxide precolumns. Anal. Chem. 76: 3935-3943.
DOI
ScienceOn
|
60 |
Posewitz, M. C. and P. Tempst. 1999. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal. Chem. 71: 2883-2892.
DOI
ScienceOn
|
61 |
Ross, C. A. and M. A. Poirier. 2004. Protein aggregation and neurodegenerative disease. Nat. Med. 10 (Suppl): S10-S17.
DOI
ScienceOn
|
62 |
Ross, C. A. and M. A. Poirier. 2005. Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6: 891-898.
DOI
ScienceOn
|
63 |
Ross, P. L., Y. N. Huang, J. N. Marchese, B. Williamson, K. Parker, S. Hattan, et al. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3: 1154-1169.
DOI
ScienceOn
|
64 |
Schmelzle, K. and F. M. White. 2006. Phosphoproteomic approaches to elucidate cellular signaling networks. Curr. Opin. Biotechnol. 17: 406-414.
DOI
ScienceOn
|
65 |
Blume-Jensen, P. and T. Hunter. 2001. Oncogenic kinase signalling. Nature 411: 355-365.
DOI
ScienceOn
|
66 |
Bates, G. 2003. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361: 1642-1644.
DOI
ScienceOn
|
67 |
Bossy-Wetzel, E., R. Schwarzenbacher, and S. A. Lipton. 2004. Molecular pathways to neurodegeneration. Nat. Med. 10 (Suppl): S2-S9.
DOI
ScienceOn
|
68 |
Beausoleil, S. A., J. Villen, S. A. Gerber, J. Rush, and S. P. Gygi. 2006. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24: 1285-1292.
DOI
ScienceOn
|
69 |
Boersema, P. J., S. Mohammed, and A. J. Heck. 2008. Hydrophilic interaction liquid chromatography (HILIC) in proteomics. Anal. Bioanal. Chem. 391: 151-159.
DOI
|
70 |
Rudrabhatla, P., P. Grant, H. Jaffe, M. J. Strong, and H. C. Pant. 2010. Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB J. 24: 4396-4407.
DOI
ScienceOn
|
71 |
Rush, J., A. Moritz, K. A. Lee, A. Guo, V. L. Goss, E. J. Spek, et al. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23: 94-101.
DOI
ScienceOn
|
72 |
Salih, E. 2005. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom. Rev. 24: 828-846.
DOI
ScienceOn
|
73 |
Schreiber, T. B., N. Mausbacher, S. B. Breitkopf, K. Grundner- Culemann, and H. Daub. 2008. Quantitative phosphoproteomics - an emerging key technology in signal-transduction research. Proteomics 8: 4416-4432.
DOI
ScienceOn
|
74 |
Schulze, W. X. and M. Mann. 2004. A novel proteomic screen for peptide-protein interactions. J. Biol. Chem. 279: 10756-10764.
|
75 |
Selkoe, D. J. 2004. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6: 1054-1061.
DOI
ScienceOn
|
76 |
Shastry, B. S. 2003. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43: 1-7.
DOI
ScienceOn
|
77 |
Smith, J. C. and D. Figeys. 2008. Recent developments in mass spectrometry-based quantitative phosphoproteomics. Biochem. Cell Biol. 86: 137-148.
DOI
ScienceOn
|
78 |
Spillantini, M. G. and M. Goedert. 1998. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21: 428-433.
DOI
ScienceOn
|
79 |
Thingholm, T. E., O. N. Jensen, P. J. Robinson, and M. R. Larsen. 2008. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell Proteomics 7: 661-671.
|
80 |
Steen, H., B. Kuster, M. Fernandez, A. Pandey, and M. Mann. 2002. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J. Biol. Chem. 277: 1031-1039.
DOI
ScienceOn
|
81 |
Tolnay, M. and A. Probst. 1999. Tau protein pathology in Alzheimer's disease and related disorders [Review]. Neuropathol. Appl. Neurobiol. 25: 171-187.
DOI
|
82 |
Stefani, M. and C. M. Dobson. 2003. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. (Berl.) 81: 678-699.
DOI
ScienceOn
|
83 |
Thingholm, T. E., O. N. Jensen, and M. R. Larsen. 2009. Analytical strategies for phosphoproteomics. Proteomics 9: 1451- 1468.
DOI
ScienceOn
|
84 |
Thingholm, T. E., T. J. Jorgensen, O. N. Jensen, and M. R. Larsen. 2006. Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 1: 1929-1935.
DOI
ScienceOn
|
85 |
Villen, J. and S. P. Gygi. 2008. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat. Protoc. 3: 1630-1638.
DOI
ScienceOn
|
86 |
Yang, X. J. 2005. Multisite protein modification and intramolecular signaling. Oncogene 24: 1653-1662.
DOI
ScienceOn
|
87 |
Zhou, H., R. Tian, M. Ye, S. Xu, S. Feng, C. Pan, et al. 2007. Highly specific enrichment of phosphopeptides by zirconium dioxide nanoparticles for phosphoproteome analysis. Electrophoresis 28: 2201-2215.
DOI
ScienceOn
|